MCE - Delayed Quote EUR

Laboratorio Reig Jofre, S.A. (RJF.MC)

2.8600
+0.1300
+(4.76%)
At close: 5:35:30 PM GMT+2
Currency in EUR All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
338,895
338,895
316,088
271,150
236,231
Cost of Revenue
143,215
143,215
137,076
113,807
91,252
Gross Profit
195,680
195,680
179,012
157,343
144,979
Operating Expense
180,601
180,601
166,580
148,135
135,614
Operating Income
15,079
15,079
12,432
9,208
9,365
Net Non Operating Interest Income Expense
-1,678
-1,678
-1,174
-895
-860
Pretax Income
11,822
11,822
10,496
8,764
5,793
Tax Provision
1,355
1,355
1,099
658
713
Net Income Common Stockholders
10,382
10,382
9,407
8,107
5,092
Diluted NI Available to Com Stockholders
10,382
10,382
9,407
8,107
5,092
Basic EPS
0.12
0.13
0.12
0.10
0.07
Diluted EPS
0.12
0.13
0.12
0.10
0.07
Basic Average Shares
80,062.8830
80,067.7280
80,063.8550
78,881.8540
77,854.0540
Diluted Average Shares
80,062.8830
80,067.7280
80,063.8550
78,881.8540
77,854.0540
Total Operating Income as Reported
12,610
12,610
10,510
8,532
8,863
Rent Expense Supplemental
1,074
1,074
916
406
711
Total Expenses
323,816
323,816
303,656
261,942
226,866
Net Income from Continuing & Discontinued Operation
10,382
10,382
9,407
8,107
5,092
Normalized Income
11,687.9402
11,687.9402
11,034.6435
9,216.9042
7,230.8089
Interest Income
287
287
63
101
50
Interest Expense
1,003
1,003
745
687
679
Net Interest Income
-1,678
-1,678
-1,174
-895
-860
EBIT
12,825
12,825
11,241
9,451
6,472
EBITDA
36,184
36,184
34,386
30,514
24,519
Reconciled Cost of Revenue
143,215
143,215
137,076
113,807
91,252
Reconciled Depreciation
23,359
23,359
23,145
21,063
18,047
Net Income from Continuing Operation Net Minority Interest
10,382
10,382
9,407
8,107
5,092
Total Unusual Items Excluding Goodwill
-1,475
-1,475
-1,818
-1,200
-2,439
Total Unusual Items
-1,475
-1,475
-1,818
-1,200
-2,439
Normalized EBITDA
37,659
37,659
36,204
31,714
26,958
Tax Rate for Calcs
0.0001
0.0001
0.0001
0.0001
0.0001
Tax Effect of Unusual Items
-169.0598
-169.0598
-190.3565
-90.0958
-300.1911
12/31/2021 - 11/29/2002

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

ALM.MC Almirall, S.A.
9.30
-0.75%
 
FAE.MC Faes Farma, S.A.
4.0150
+3.61%
 
ROVI.MC Laboratorios Farmaceuticos Rovi, S.A.
49.60
+1.14%
 
ZTS Zoetis Inc.
149.99
+2.14%